KOMPOSITION

The pharmaceutical composition comprises a compound which inhibits the release of mediators of anaphylaxis, such as sodium cromoglycate, in combination with sulphasalazine or an aminosalicylate. The composition of the invention may be used, in particular, for the treatment of gastrointestinal disord...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CHAMBERS ALBERT, WORSLEY JOHN LAWRENCE
Format:	Patent
Sprache:	fin
Schlagworte:	ACTUATING-FLOATS BLASTING CHEMISTRY COCKS CYLINDERS DEVICES FOR VENTING OR AERATING ENGINEERING ELEMENTS AND UNITS GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVEFUNCTIONING OF MACHINES OR INSTALLATIONS HEATING HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE LIGHTING MECHANICAL ENGINEERING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PISTONS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SEALINGS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TAPS THERMAL INSULATION IN GENERAL VALVES WEAPONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The pharmaceutical composition comprises a compound which inhibits the release of mediators of anaphylaxis, such as sodium cromoglycate, in combination with sulphasalazine or an aminosalicylate. The composition of the invention may be used, in particular, for the treatment of gastrointestinal disorders.